Evidence map›Paper›PMID 32211509›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2020

Effectiveness of online education for recruitment to an Alzheimer's disease prevention clinical trial.

Nabeel Saif, Cara Berkowitz, Susmit Tripathi, Olivia Scheyer, Emily Caesar, Hollie Hristov, Katherine Hackett, Aneela Rahman, Newman Knowlton, George Sadek and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Strategies to improve recruitment to randomised trials.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Nabeel SaifDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Cara BerkowitzDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Susmit TripathiDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Olivia ScheyerSchool of Law University of California Los Angeles Los Angeles California.
Emily CaesarLoyola School of Medicine Chicago Illinois.
Hollie HristovDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Katherine HackettDepartment of Psychology Temple University Philadelphia Pennsylvania.
Aneela RahmanDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Newman KnowltonBiostatistics Pentara Corporation Salt Lake City Utah.
George SadekDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Paige LeeCollege of Letters and Science University of California Los Angeles Los Angeles California.
Mark McInnisWishbone Productions Boston Massachusetts.
Richard S IsaacsonDepartment of Neurology Weill Cornell Medicine & New York-Presbyterian New York New York.
Presbyterian Hospital · USCornell University · USUniversity of California, Los Angeles · USLoyola Medicine · USMassachusetts Audubon Society · USTemple University · USTetraLogic Pharmaceuticals (United States) · US

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Timing of Menopausal Hormone Therapy across Perimenopause to Menopause Transition: Neuroimmune System in BrainP01AG026572 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERTA EILEEN BRINTON · 2006 to 2026
$53.7M
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyR01AG063689 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI AISEN, PAUL S., SPERLING, REISA A. · 2019 to 2024
$30.8M
NCATS NIH HHS UL1 TR002384NIA NIH HHS P01 AG026572NIA NIH HHS R01 AG063689
6 · The paper itself

Abstract

introductionLow awareness of Alzheimer's disease (AD) clinical trials is a recruitment barrier. To assess whether online education may affect screening rates for AD prevention clinical trials, we conducted an initial prospective cohort study (n = 10,450) and subsequent randomized study (n = 351) using an online digital tool: AlzU.org.

methodsA total of 10,450 participants were enrolled in an initial cohort study and asked to complete a six-lesson course on AlzU.org, as well as a baseline and 6-month follow-up questionnaire. Participants were stratified into three groups based on lesson completion at 6 months: group 1 (zero to one lesson completed), group 2 (two to four lessons), and group 3 (five or more lessons). For the subsequent randomized-controlled trial (RCT), 351 new participants were enrolled in a six-lesson course (n = 180) versus a time-neutral control (n = 171). Screening and enrollment in the Anti-Amyloid Treatment in Asymptomatic AD (A4) clinical trial were reported via the 6-month questionnaire and are the primary outcomes.

resultsDISCUSSION: Online education via the AlzU.org digital tool may serve as an effective strategy to supplement clinical trial recruitment.

Indexed as

Alzheimer's diseaseAlzheimer's prevention clinical trialsclinical trial screeningdigital toole‐learningonline education

Identifiers

PMID32211509
PMCPMC7085257
OpenAlexW3012284584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.